2-202034761-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003507.2(FZD7):āc.114G>Cā(p.Glu38Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,612,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003507.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FZD7 | NM_003507.2 | c.114G>C | p.Glu38Asp | missense_variant | 1/1 | ENST00000286201.3 | NP_003498.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FZD7 | ENST00000286201.3 | c.114G>C | p.Glu38Asp | missense_variant | 1/1 | 6 | NM_003507.2 | ENSP00000286201.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250970Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135768
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1460296Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 17AN XY: 726448
GnomAD4 genome AF: 0.000151 AC: 23AN: 152306Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.114G>C (p.E38D) alteration is located in exon 1 (coding exon 1) of the FZD7 gene. This alteration results from a G to C substitution at nucleotide position 114, causing the glutamic acid (E) at amino acid position 38 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at